Key result
Cardiac biomarkers, particularly highly sensitive and specific markers of myocardial necrosis, are essential for the early diagnosis and risk stratification of acute coronary syndromes.
Cardiac biomarkers, particularly troponins and point-of-care tests, are essential for the rapid diagnosis and risk stratification of acute coronary syndromes.
Cardiac biomarkers are standard part of contemporary cardiology practice. They reflect basic pathophysiological processes that underlie acute coronary syndromes: damage and necrosis of myocardial cells, inflammation, neurohumoral activation and changes in left ventricular and renal function. Ideal goal is to find a marker that would have high sensitivity and specificity in early phases of acute coronary syndromes. Breakthroughs in technology resulted in an array of 'pointof- care' (POC) tests that are becoming increasingly important, due to rapid results of testing. .
No takes yet. Share an insight, caveat, or question.
Sladjana Virijevic (2012) conducted a review in Acute coronary syndrome. Cardiac biomarkers was evaluated. Cardiac biomarkers, particularly highly sensitive and specific markers of myocardial necrosis, are essential for the early diagnosis and risk stratification of acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: